Platelet-activating factor stimulates phospholipase C activity in human endometrium

Area of Science:

• Reproductive Endocrinology
• Cellular Signaling
• Human Embryology

Background:

• Human embryos secrete platelet-activating factor (PAF).
• PAF stimulates prostaglandin E2 synthesis in the secretory endometrium.
• The role of PAF in endometrial receptivity requires further investigation.

Purpose of the Study:

• To investigate the action of PAF on phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2)-specific phospholipase C activity in human endometrium.
• To determine the phase-specificity of the PAF response in the menstrual cycle.
• To elucidate the mechanism of PAF signaling in the endometrium.

Main Methods:

• Human endometrial slices were incubated with myo-[2-3H] inositol to label phosphoinositides.
• Inositol phosphates were extracted and quantified using anion-exchange chromatography.
• The effect of PAF and its antagonist WEB 2086 on PtdIns(4,5)P2 hydrolysis was measured.

Main Results:

• PAF induced a rapid, concentration-dependent accumulation of inositol phosphates (IP) in secretory endometrium.
• No effect of PAF was observed in proliferative phase endometrium.
• PAF-induced PtdIns(4,5)P2 hydrolysis was blocked by the PAF receptor antagonist WEB 2086, confirming receptor mediation.
• The response was specific to the secretory phase, suggesting ovarian steroid regulation.

Conclusions:

• PAF receptor activation triggers endometrial PtdIns(4,5)P2-specific phospholipase C activity exclusively during the secretory phase.
• This PAF-induced signaling pathway is likely regulated by ovarian steroids.
• Endometrial responsiveness to PAF is critical for implantation and maternal recognition of early pregnancy.